Find companies:

ImClone Systems Incorporated

Compensation/Benefits
Management
Job Security/Advancement
Job Culture
Job Work/Life Balance
1 review

About ImClone Systems Incorporated

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer. The Company focuses on two systems for treating cancer: growth factor blockers and angiogenesis inhibitors. Its commercially available product, ERBITUX (cetuximab), – more... is an antibody approved by the United States Food and Drug Administration (FDA). On March 1, 2006, the FDA approved ERBITUX for use in combination with radiation therapy for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck (SCCHN) and as a single agent in recurrent or metastatic SCCHN. In addition to developing and commercializing ERBITUX, the Company has also advanced a number of investigational agents to various stages of clinical development, including those targeting angiogenesis and growth signaling mechanisms, which can be used to treat various kinds of cancer and other diseases. – lessMore from ZoomInfo »

ImClone Systems Incorporated Employer Reviews

Bright and hard working people. Great place to work in science and be in the city.
Research Scientist (Former Employee), New York, NY – April 26, 2012

ImClone Systems Incorporated Photos

Working at ImClone Systems Incorporated